Latest News & Features
Americas
American medical device maker ResMed and New Zealand-based competitor Fisher & Paykel have agreed to settle a global patent dispute over medical devices. 22 February 2019
Americas
Indivior has launched a generic version of its opioid addiction drug Suboxone (buprenorphine and naloxone) Film, one day after the US Supreme Court denied its request to put a lower court’s ruling on hold. 22 February 2019
Americas
The majority parliament group of the Mexican Senate has introduced a bill to modify the current scheme for setting maximum sale prices of patented medicines and supplies. 21 February 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday disqualified law firm Katten Muchin Rosenman from representing Mylan in three appeals before the court. 21 February 2019
Europe
The EU’s Community Plants Variety Office has issued an information notice advising that owners of EU Community plant variety rights issued after January 29, 2019 will need to re-apply for equivalent UK rights in the event of a no-deal Brexit. 20 February 2019
Generics
Teva Pharmaceutical and the US Federal Trade Commission have reached a settlement to end their long-running battles over so called “pay-for-delay” agreements in the pharmaceutical industry. 20 February 2019
Americas
The US Food and Drug Administration has published new draft guidance on a pathway intended to boost the development of generics and lower drug prices. 19 February 2019
Big Pharma
While the final text of the European Council’s agreement on a supplementary protection certificate manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism. 19 February 2019
Europe
The Court of Justice of the European Union has issued a judgment in favour of Warner-Lambert amid a dispute between the American pharmaceutical company and an administrative body in the Netherlands. 18 February 2019
Americas
Johnson & Johnson has announced plans to strengthen its robotics programme with the addition of Silicon Valley-based Auris Health to its business. 18 February 2019